MedTrace Logo

Identify microRNAs in Cachexia in Pancreatic Carcinoma

NCT05275075 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the genes between patient groups.

Conditions

  • Resectable Pancreatic Adenocarcinoma

Interventions

OTHER

Pancreatic cancer microRNA and messenger RNA expression.

Tumor specimens from pancreatic patients will be analyzed for markers associated with muscle loss.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Ajay Jain, MD · University of Oklahoma Stephenson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-07
Primary Completion
2026-05-01
Completion
2029-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05275075 on ClinicalTrials.gov